Impact of BCL2 polymorphisms on survival in transitional cell carcinoma of the bladder
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Cancer Research and Clinical Oncology"
DOI: 10.1007/s00432-017-2404-8
Abstract: PurposeTo evaluate the impact of three BCL2 single-nucleotide polymorphisms, i.e., c.−938C>A (rs2279115), c.21G>A (rs1801018), and c.*2203A>G (rs4987853) on survival in patients with transitional cell carcinoma of the bladder.MethodsWe analyzed 179 patients who underwent surgical treatment… read more here.
Keywords: transitional cell; cell carcinoma; impact; bladder ... See more keywords
Small‐Cell Carcinoma of the Bladder: 20‐Year Single‐Institution Retrospective Review
Sign Up to like & getrecommendations! Published in 2017 at "Clinical Genitourinary Cancer"
DOI: 10.1016/j.clgc.2016.09.005
Abstract: Micro‐Abstract We performed a retrospective survival analysis of 38 patients with small‐cell carcinoma of the bladder treated at our institution. In multivariable adjusted analysis, we could not find any significant survival advantage associated with neoadjuvant… read more here.
Keywords: chemotherapy; cell carcinoma; neoadjuvant chemotherapy; small cell ... See more keywords
Treatment Patterns and Survival Outcomes for Patients with Small Cell Carcinoma of the Bladder.
Sign Up to like & getrecommendations! Published in 2018 at "European urology focus"
DOI: 10.1016/j.euf.2017.09.001
Abstract: BACKGROUND Small cell carcinoma of the bladder (SCCaB) is a rare tumor without a standard treatment algorithm. Treatment patterns and survival outcomes from the National Cancer Database (NCDB) may provide insight into optimal treatment strategies.… read more here.
Keywords: cell carcinoma; treatment; small cell; carcinoma bladder ... See more keywords
Pulmonary manifestations of urothelial carcinoma of the bladder.
Sign Up to like & getrecommendations! Published in 2017 at "Respiratory medicine"
DOI: 10.1016/j.rmed.2017.05.006
Abstract: Urothelial carcinoma (Transitional cell carcinoma) of the bladder is the pre-dominant histological type of bladder cancer in the United States and Europe. Patients with bladder cancer usually present with painless hematuria. The diagnosis is often… read more here.
Keywords: bladder cancer; carcinoma; bladder; urothelial carcinoma ... See more keywords
Adjuvant immunotherapy for muscle-invasive urothelial carcinoma of the bladder
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Anticancer Therapy"
DOI: 10.1080/14737140.2022.2038565
Abstract: ABSTRACT Introduction There are substantial unmet needs with regards to adjuvant therapy for muscle-invasive urothelial carcinoma (UC) of the bladder, including patients with persistent disease histologically following neoadjuvant platinum-based therapy and radical resection, as well… read more here.
Keywords: carcinoma bladder; immunotherapy; invasive urothelial; urothelial carcinoma ... See more keywords
Plasmacytoid Variant Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-analysis of the Clinicopathological Features and Survival Outcomes.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Urology"
DOI: 10.1097/ju.0000000000000794
Abstract: PURPOSE The clinicopathological features and treatment outcomes of plasmacytoid variant (PV)-urothelial carcinoma of the bladder (UCB) have not been fully understood. We aimed to evaluate the clinicopathologic characteristics and survival outcomes of PV-UCB as compared… read more here.
Keywords: variant urothelial; survival outcomes; carcinoma bladder; clinicopathological features ... See more keywords
CSTF2-Induced Shortening of the RAC1 3'UTR Promotes the Pathogenesis of Urothelial Carcinoma of the Bladder.
Sign Up to like & getrecommendations! Published in 2018 at "Cancer research"
DOI: 10.1158/0008-5472.can-18-0822
Abstract: Shortening of the 3' untranslated regions (3'UTR) of mRNA is an important mechanism for oncogene activation. However, 3'UTR alteration events, their pathologic functions, and underlying mechanisms in human urothelial carcinoma of the bladder (UCB) are… read more here.
Keywords: cstf2; cstf2 induced; isoform; urothelial carcinoma ... See more keywords
Altered expression of small leucine-rich proteoglycans (Decorin, Biglycan and Lumican): Plausible diagnostic marker in urothelial carcinoma of bladder
Sign Up to like & getrecommendations! Published in 2017 at "Tumor Biology"
DOI: 10.1177/1010428317699112
Abstract: Small leucine-rich proteoglycans are components of extracellular matrix that regulates neoplastic transformation. Among small leucine rich proteoglycans, Decorin, Biglycan and Lumican are most commonly implicated markers, and their expression is well studied in various malignancies.… read more here.
Keywords: bladder; small leucine; expression; urothelial carcinoma ... See more keywords
Multiple primary malignancies: synchronous urothelial carcinoma of the bladder and adenocarcinoma of the colon
Sign Up to like & getrecommendations! Published in 2017 at "Radiologia Brasileira"
DOI: 10.1590/0100-3984.2015.0114
Abstract: Radiol Bras. 2017 Jan/Fev;50(1):62–68 64 http://dx.doi.org/10.1590/0100-3984.2015.0159 The symptoms of SMD vary depending on the age of the patients, the principal symptoms being as follows: limited postnatal growth; rhizomelic shortening of the limbs in early childhood… read more here.
Keywords: multiple primary; malignancies synchronous; synchronous urothelial; primary malignancies ... See more keywords
Prognostic Value of Vascular-Expressed PSMA and CD248 in Urothelial Carcinoma of the Bladder
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.771036
Abstract: Background Urothelial carcinoma of the bladder (UCB) is a common cancer of the urinary system. Despite substantial improvements in available treatment options, the survival outcome of patients with advanced UCB is unsatisfactory. Therefore, it is… read more here.
Keywords: expression; carcinoma bladder; urothelial carcinoma; cd248 ... See more keywords
CA125 for the Diagnosis of Advanced Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-Analysis
Sign Up to like & getrecommendations! Published in 2023 at "Cancers"
DOI: 10.3390/cancers15030813
Abstract: Simple Summary Urothelial carcinoma of the bladder (UCB) is a common genitourinary cancer. Advanced UCB, defined as muscle-invasive and lymph node-involving, is linked to poor outcomes. CA125 is a well-known tumor marker for ovarian cancer… read more here.
Keywords: ca125; advanced ucb; carcinoma bladder; urothelial carcinoma ... See more keywords